This article is more than 5 years old. Information may no longer be current.
Physician joins CCP committee
Dale Shepard
Dale Shepard, MD, PhD, co-director of the Taussig Oncology Program for Seniors and staff physician in the department of solid tumor oncology at Cleveland Clinic’s Taussig Cancer Institute, has been selected as a member of the Alliance Cancer Control Program’s Cancer in the Elderly Committee.
The program, part of the Alliance for Clinical Trials in Oncology, conducts innovative scientific studies — including interventional, methodological and health policy research — to help reduce the incidence, morbidity and mortality of cancer in broad populations.
CCP is designed to help researchers better understand the factors that affect cancer risk, identify opportunities to prevent cancer or reduce the impact of cancer and/or its treatment on the patient, improve patient quality of life, and evaluate the feasibility and effectiveness of strategies to prevent and control cancer in academic settings, the community and in underserved populations.